All lobbying filings
CGCN GROUP, LLC
CGCN GROUP, LLC filed a Q2 report for PARTNER THERAPEUTICS, INC. on July 19, 2026, reporting $80,000 in lobbying income.
Lobbying for PARTNER THERAPEUTICS, INC. · Biopharmaceutical company
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 19, 2026
Income
$80,000
What the client paid this registrant for the period.
Client based in
Massachusetts
Government bodies contacted
5
Lobbying activity
2
Issues pertaining to the development of public health emergency medical countermeasures. Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act.
Issues related to medical countermeasures for Acute Radiation Syndrome (ARS).